Simvastatin
Who holds supplier records for Simvastatin? 16 organisations hold a current record for Simvastatin: an active US FDA Type II Drug Master File or a CEP. A further 14 organisations have only historical (inactive) DMF filings. 14 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6), China (5), Israel (1) and Netherlands (1); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Simvastatin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/simvastatin
Reading the evidence
- 16 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Simvastatin expires 23 Feb 2030. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (16)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Simvastatin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Teva Pharmaceutical Industries Ltd.IsraelCEP Company GMP cert on recordActive DMF 14599, 25024 · latest filing Jun 2011
- Zhejiang Jiangbei Pharmaceutical Co., Ltd.ChinaCEPActive DMF 26971, 28583 · latest filing Aug 2014
- Biocon LimitedIndiaCEPActive DMF 18449, 16094 · latest filing Jun 2005
- HENAN TOPFOND SCI-TECH CO LTDChinaCEPActive DMF 34089 · latest filing Aug 2019
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 23012, 27231 · latest filing Jun 2013
- Lupin LimitedIndiaCEP Company GMP cert on recordActive DMF 17934 · latest filing Dec 2004
- ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO LTDCEP Company GMP cert on recordActive DMF 40384 · latest filing Sept 2024
- JUBILANT BIOSYS LTDIndiaActive DMF 18755 · latest filing Sept 2005
- SOUTHWEST SYNTHETIC PHARMACEUTICAL CORP LTDChinaActive DMF 23425 · latest filing Dec 2009
- ARTEMIS BIOTECHCEPInactive DMF 18522 · latest filing Jul 2005
- KREBS BIOCHEMICALS AND INDUSTRIES LTDCEP Company GMP cert on record
- Shaoxing Jingxin Pharmaceutical Co., Ltd.ChinaCEP
- Sun Pharmaceutical Industries LimitedIndiaCEP Company GMP cert on recordInactive DMF 15722 · latest filing Nov 2001
- NetherlandsCEP
- Zhejiang Hisun Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordInactive DMF 26048, 16305 · latest filing May 2012
- Artemis Biotech (A Division of Themis Medicare Limited)IndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (14)
Certificates of Suitability on the EDQM register for Simvastatin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 46 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| BIOCON LIMITED Bengaluru | IN | CEP 2012-337 - Rev 04 Simvastatin | Nov 2026 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2013-216 - Rev 04 Simvastatin, Ethanol/acetonitrile process | Jun 2026 | — |
| SHAOXING JINGXIN PHARMACEUTICAL CO., LTD. Shangyu | CN | CEP 2017-184 - Rev 04 Simvastatin, BHA process | Aug 2025 | — |
| ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO., LTD Linhai City | CN | CEP 2022-245 - Rev 02 Simvastatin | Mar 2025 | Inspected Oct 2025 France |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | CEP 2001-384 - Rev 09 Simvastatin | Feb 2025 | — |
| ARTEMIS BIOTECH LIMITED Hyderabad | IN | CEP 2023-416 - Rev 00 Simvastatin, Process II, Antioxidant Butylated Hydroxy Toluene 0.01% | Apr 2024 | — |
| KREBS BIOCHEMICALS & INDUSTRIES LIMITED Kothapalli | IN | R1-CEP 2007-210 - Rev 02 Simvastatin, with 0.2% butylated hydroxy anisole | Aug 2023 | — |
| HENAN TOPFOND SCI-TECH CO., LTD. Zhumadian | CN | R1-CEP 2006-232 - Rev 04 Simvastatin | Mar 2022 | — |
| TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa | IL | R1-CEP 2013-338 - Rev 01 Simvastatin, Ethanol/acetonitrile/BHA process | Dec 2021 | — |
| HETERO LABS LIMITED Hyderabad | IN | R1-CEP 2014-058 - Rev 00 Simvastatin | Aug 2021 | — |
| Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City | CN | R1-CEP 2002-172 - Rev 04 Simvastatin | Mar 2021 | — |
| LUPIN LIMITED Mumbai | IN | R1-CEP 2005-100 - Rev 06 Simvastatin | Aug 2020 | — |
| Artemis Biotech (A Division of Themis Medicare Limited) Hyderabad | IN | R1-CEP 2006-091 - Rev 03 Simvastatin, Butylated Hydroxy Anisole 50 - 150 ppm | May 2020 | — |
| ZHEJIANG JIANGBEI PHARMACEUTICAL CO., LTD. Taizhou City | CN | R1-CEP 2013-025 - Rev 03 Simvastatin, Antioxidant butylated hydroxyanisole | Jul 2019 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (14)
Organisations whose Type II DMFs for Simvastatin are no longer active. These show a past filing, not current supply.
Show all 14 historical records
- United States · Inactive DMF 30837 · filed Jul 2016
- China · Inactive DMF 27438 · filed Aug 2013
- SANDOZ INDUSTRIAL PRODUCTS SPAInactive DMF 22283 · filed Dec 2008
- India · Inactive DMF 21265 · filed Jan 2008
- MYLAN LABORATORIES LTDInactive DMF 20903 · filed Oct 2007
- India · Inactive DMF 18223, 20125, 20373 · filed Mar 2007
- India · Inactive DMF 19044 · filed Dec 2005
- Netherlands · Inactive DMF 18384 · filed May 2005
- ZHEJIANG APELOA PHARMACEUTICAL CO LTDInactive DMF 18309 · filed Apr 2005
- China · Inactive DMF 18101 · filed Jan 2005
- India · Inactive DMF 17959 · filed Dec 2004
- India · Inactive DMF 17829 · filed Nov 2004
- Slovenia · Inactive DMF 17568 · filed Jul 2004
- KREBS BIOCHEMICALS INDUSTRIES LTDInactive DMF 17151 · filed Feb 2004
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (55 listed products contain Simvastatin). The latest listed patent expires 23 Feb 2030. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Simvastatin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1064).
Chemical identity
- IUPAC name
- [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
- Canonical SMILES
- CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C
- InChIKey
- RYMZZMVNJRMUDD-HGQWONQESA-N
- Synonyms
- C10AA01, Flolipid, Lacersa, MK-0733, MK-733, NSC-758706, Ranzolont, Simvador, Simvastatin, Simvastatina, Simvastatin component of juvisync, Simvastatin component of polycap
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- HMG-CoA Reductase Inhibitor
- Mechanism of action
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Simvastatin?
16 organisations hold an active US FDA Type II Drug Master File or a CEP for Simvastatin: Teva Pharmaceutical Industries Ltd. (Israel), Zhejiang Jiangbei Pharmaceutical Co., Ltd. (China), Biocon Limited (India), HENAN TOPFOND SCI-TECH CO LTD (China), Hetero Labs Limited (India), Lupin Limited (India), ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO LTD and JUBILANT BIOSYS LTD (India), and 8 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Simvastatin Drug Master Files are active?
Teva Pharmaceutical Industries Ltd. (DMF 14599, 25024), Zhejiang Jiangbei Pharmaceutical Co., Ltd. (DMF 26971, 28583), Biocon Limited (DMF 18449, 16094), HENAN TOPFOND SCI-TECH CO LTD (DMF 34089), Hetero Labs Limited (DMF 23012, 27231), Lupin Limited (DMF 17934), ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO LTD (DMF 40384) and JUBILANT BIOSYS LTD (DMF 18755) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Simvastatin records mean?
14 organisations have only inactive Type II DMFs for Simvastatin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Simvastatin have a European Certificate of Suitability?
Yes. 14 organisations hold a valid CEP for Simvastatin on the EDQM register, including BIOCON LIMITED Bengaluru (IN), TAPI NL B.V. Amsterdam (NL), SHAOXING JINGXIN PHARMACEUTICAL CO., LTD. Shangyu (CN), ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO., LTD Linhai City (CN), SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN) and ARTEMIS BIOTECH LIMITED Hyderabad (IN) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Simvastatin?
Yes. The latest patent listed for an approved US product containing Simvastatin expires 23 Feb 2030, across 55 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Simvastatin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Simvastatin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.